The role of gut brain axis in the pathogenesis of Parkinson's disease
DOI:
https://doi.org/10.61173/ncvcev37Keywords:
Parkinson disease, gut‑brain axis, α-synuclein, intestinal barrier, neuroinflammationAbstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder traditionally characterized by dopaminergic neuronal loss and α-synuclein aggregation within the central nervous system. However, increasing evidence suggests that the disease may originate outside the brain, particularly within the gastrointestinal tract, through mechanisms involving the microbiota–gut–brain axis (MGBA). This article summarizes the interactions between intestinal dysfunction, barrier dysfunction, inflammation, and α- synuclein transmission along the vagus nerve in the pathogenesis of Parkinson's disease. Alterations in microbial composition are closely linked with impaired intestinal barrier integrity, leading to neuroinflammation and dopaminergic neuron degeneration. Clinical studies further support the causal role of gut-derived signals in shaping disease onset and progression. Additionally, intestinal-derived α-synuclein has been demonstrated to propagate retrogradely to the brainstem via the vagus nerve, reinforcing the “gut-origin hypothesis.” By integrating microbiology, neuroscience, and immunology, the study of MGBA not only broadens our understanding of PD etiology but also highlights novel targets for prevention and personalized therapeutic strategies.
References
[1] Brakedal, B., Toker, L., Haugarvoll, K., & Tzoulis, C. (2022). A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population. NPJ Parkinson’s disease, 8(1), 19. https://doi.org/10.1038/s41531- 022-00280-4.
[2] Park, S. J., Kim, K. W., & Lee, E. J. (2025). Gut-brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression. Neural regeneration research, 20(12), 3416–3429. https://doi.org/10.4103/NRR. NRR-D-24-00994.
[3] Schaeffer, E., Kluge, A., Böttner, M., Zunke, F., Cossais, F., Berg, D., & Arnold, P. (2020). Alpha Synuclein Connects the Gut-Brain Axis in Parkinson’s Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology. Frontiers in cell and developmental biology, 8, 573696. https://doi.org/10.3389/fcell.2020.573696.
[4] Chen, M., & Mor, D. E. (2023). Gut-to-Brain α-Synuclein Transmission in Parkinson’s Disease: Evidence for Prion-like Mechanisms. International journal of molecular sciences, 24(8), 7205. https://doi.org/10.3390/ijms24087205.
[5] Oliver, P. J., Civitelli, L., & Hu, M. T. (2025). The gut-brain axis in early Parkinson’s disease: from prodrome to prevention. Journal of neurology, 272(6), 413. https://doi.org/10.1007/ s00415-025-13138-5.
[6] Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024). Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal transduction and targeted therapy, 9(1), 37. https://doi.org/10.1038/s41392-024-01743-1.
[7] Longo, S., Rizza, S., & Federici, M. (2023). Microbiota-gutbrain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes. Acta diabetologica, 60(8), 1007–1017. https://doi.org/10.1007/s00592-023-02088-x.
[8] Jameson, K. G., Kazmi, S. A., Ohara, T. E., Son, C., Yu, K. B., Mazdeyasnan, D., Leshan, E., Vuong, H. E., Paramo, J., Lopez- Romero, A., Yang, L., Schweizer, F. E., & Hsiao, E. Y. (2024). Select microbial metabolites in the small intestinal lumen regulate vagal activity via receptor-mediated signaling. iScience, 28(2), 111699. https://doi.org/10.1016/j.isci.2024.111699. Dean&Francis ISSN 2959-409X
[9] Sharkey, K. A., & Mawe, G. M. (2023). The enteric nervous system. Physiological reviews, 103(2), 1487–1564. https://doi. org/10.1152/physrev.00018.2022.
[10] Kerstens, R., & Joyce, P. (2024). The Gut Microbiome as a Catalyst and Emerging Therapeutic Target for Parkinson’s Disease: A Comprehensive Update. Biomedicines, 12(8), 1738. https://doi.org/10.3390/biomedicines12081738.
[11] Wang, L., Cui, Y., Han, B., Du, Y., Salewala, K. S., Wang, S., Zhao, W., Zhang, H., Wang, S., Xu, X., Ma, J., Zhu, Y., & Tuo, H. (2025). Gut microbiota and Parkinson’s disease. Chinese medical journal, 138(3), 289–297. https://doi.org/10.1097/ CM9.0000000000003318.
[12] Feng, M., Zou, Z., Shou, P., Peng, W., Liu, M., & Li, X. (2024). Gut microbiota and Parkinson’s disease: potential links and the role of fecal microbiota transplantation. Frontiers in aging neuroscience, 16, 1479343. https://doi.org/10.3389/ fnagi.2024.1479343.
[13] Panaitescu, P. Ș., Răzniceanu, V., Mocrei-Rebrean, Ș. M., Neculicioiu, V. S., Dragoș, H. M., Costache, C., & Filip, G. A. (2024). The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson’s Disease Animal Models-A Systematic Review. Current issues in molecular biology, 46(5), 3946–3974. https://doi.org/10.3390/ cimb46050244.
[14] Yang, R., Gao, G., & Yang, H. (2022). The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson’s Disease. Frontiers in aging neuroscience, 14, 861035. https://doi.org/10.3389/fnagi.2022.861035.
[15] Chandra, R., Sokratian, A., Chavez, K. R., King, S., Swain, S. M., Snyder, J. C., West, A. B., & Liddle, R. A. (2023). Gut mucosal cells transfer α-synuclein to the vagus nerve. JCI insight, 8(23), e172192. https://doi.org/10.1172/jci. insight.172192.
[16] Liu, B., Fang, F., Pedersen, N. L., Tillander, A., Ludvigsson, J. F., Ekbom, A., Svenningsson, P., Chen, H., & Wirdefeldt, K. (2017). Vagotomy and Parkinson disease: A Swedish registerbased matched-cohort study. Neurology, 88(21), 1996–2002. https://doi.org/10.1212/WNL.0000000000003961.
[17] Takahashi, R., Yamakado, H., Uemura, N., Taguchi, T., & Ueda, J. (2025). The Gut-Brain Axis Based on α-Synuclein Propagation-Clinical, Neuropathological, and Experimental Evidence. International journal of molecular sciences, 26(9), 3994. https://doi.org/10.3390/ijms26093994.
[18] Dumitrescu, L., Marta, D., Dănău, A., Lefter, A., Tulbă, D., Cozma, L., Manole, E., Gherghiceanu, M., Ceafalan, L. C., & Popescu, B. O. (2021). Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson’s Disease. Frontiers in neuroscience, 15, 689723. https://doi.org/10.3389/fnins.2021.689723.
[19] Klann, E. M., Dissanayake, U., Gurrala, A., Farrer, M., Wagle Shukla, A., Ramirez-Zamora, A., Mai, V., & Vedam-Mai, V. (2022). The Gut-Brain Axis and Its Relation to Parkinson’s Disease: A Review. Frontiers in aging neuroscience, 13, 782082. https://doi.org/10.3389/fnagi.2021.782082.
[20] Shannon K. M. (2022). Gut-Derived Sterile Inflammation and Parkinson’s Disease. Frontiers in neurology, 13, 831090. https://doi.org/10.3389/fneur.2022.831090.
[21] Brown, G. C., Camacho, M., & Williams-Gray, C. H. (2023). The Endotoxin Hypothesis of Parkinson’s Disease. Movement disorders : official journal of the Movement Disorder Society, 38(7), 1143–1155. https://doi.org/10.1002/mds.29432.
[22] Milde, S., van Tartwijk, F. W., Vilalta, A., Hornik, T. C., Dundee, J. M., Puigdellívol, M., & Brown, G. C. (2021). Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice. Journal of neuroinflammation, 18(1), 225. https://doi.org/10.1186/s12974-021-02280-2.
[23] Deng, I., & Bobrovskaya, L. (2022). Lipopolysaccharide mouse models for Parkinson’s disease research: a critical appraisal. Neural regeneration research, 17(11), 2413–2417. https://doi.org/10.4103/1673-5374.331866.
[24] Yang, H., Li, S., & Le, W. (2022). Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease. Aging and disease, 13(5), 1381–1390. https://doi.org/10.14336/AD.2022.01281.
[25] Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022). Inflammation and immune dysfunction in Parkinson disease. Nature reviews. Immunology, 22(11), 657–673. https://doi.org/10.1038/s41577-022-00684-6.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
